Unknown

Dataset Information

0

RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers.


ABSTRACT:

Background

Sessile serrated adenomas/polyps (SSA/Ps) may account for 20-30% of colon cancers. Although large SSA/Ps are generally recognized phenotypically, small (<1 cm) or dysplastic SSA/Ps are difficult to differentiate from hyperplastic or small adenomatous polyps by endoscopy and histopathology. Our aim was to define the comprehensive gene expression phenotype of SSA/Ps to better define this cancer precursor.

Results

RNA sequencing was performed on 5' capped RNA from seven SSA/Ps collected from patients with the serrated polyposis syndrome (SPS) versus eight controls. Highly expressed genes were analyzed by qPCR in additional SSA/Ps, adenomas and controls. The cellular localization and level of gene products were examined by immunohistochemistry in syndromic and sporadic SSA/Ps, adenomatous and hyperplastic polyps and controls. We identified 1,294 differentially expressed annotated genes, with 106 increased ?10-fold, in SSA/Ps compared to controls. Comparing these genes with an array dataset for adenomatous polyps identified 30 protein coding genes uniquely expressed ?10-fold in SSA/Ps. Biological pathways altered in SSA/Ps included mucosal integrity, cell adhesion, and cell development. Marked increased expression of MUC17, the cell junction protein genes VSIG1 and GJB5, and the antiapoptotic gene REG4 were found in SSA/Ps, relative to controls and adenomas, were verified by qPCR analysis of additional SSA/Ps (n?=?21) and adenomas (n?=?10). Immunohistochemical staining of syndromic (n?11) and sporadic SSA/Ps (n?17), adenomatous (n?13) and hyperplastic (n?10) polyps plus controls (n?16) identified unique expression patterns for VSIG1 and MUC17 in SSA/Ps.

Conclusion

A subset of genes and pathways are uniquely increased in SSA/Ps, compared to adenomatous polyps, thus supporting the concept that cancer develops by different pathways in these phenotypically distinct polyps with markedly different gene expression profiles. Immunostaining for a subset of these genes differentiates both syndromic and sporadic SSA/Ps from adenomatous and hyperplastic polyps.

SUBMITTER: Delker DA 

PROVIDER: S-EPMC3922809 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers.

Delker Don A DA   McGettigan Brett M BM   Kanth Priyanka P   Pop Stelian S   Neklason Deborah W DW   Bronner Mary P MP   Burt Randall W RW   Hagedorn Curt H CH  

PloS one 20140212 2


<h4>Background</h4>Sessile serrated adenomas/polyps (SSA/Ps) may account for 20-30% of colon cancers. Although large SSA/Ps are generally recognized phenotypically, small (<1 cm) or dysplastic SSA/Ps are difficult to differentiate from hyperplastic or small adenomatous polyps by endoscopy and histopathology. Our aim was to define the comprehensive gene expression phenotype of SSA/Ps to better define this cancer precursor.<h4>Results</h4>RNA sequencing was performed on 5' capped RNA from seven SS  ...[more]

Similar Datasets

| S-EPMC4941619 | biostudies-literature
| S-EPMC6437779 | biostudies-literature
2014-04-29 | GSE46513 | GEO
2014-04-29 | E-GEOD-46513 | biostudies-arrayexpress
2016-04-08 | GSE76987 | GEO
2018-10-18 | GSE118504 | GEO
| S-EPMC5745747 | biostudies-literature
| S-EPMC6970553 | biostudies-literature
| S-EPMC5372551 | biostudies-literature
| S-EPMC8653879 | biostudies-literature